 Hyperlipidemia fatty acid composition patients type IA glycogen storage disease glycogen storage disease type IA GSD-IA recurrent episodes hypoglycemia marked elevation blood triglyceride levels plasma lipid levels patients GSD-IA regular basis patients fatty acid composition possible essential fatty acid deficiency urinary prostaglandin excretion patients triglyceride levels mg/dl mmol/L treatment treatment blood glucose levels mg/dl mmol/L triglyceride levels patients mmol/L mg/dl mmol/L lipoprotein fatty acid composition patients substantial elevation increase fatty acid essential fatty acid deficiency addition patients normal urinary excretion prostaglandin patient triglyceride levels elevated dietary treatment clofibrate lovastatin niacin fish oil exception lovastatin agents decrease triglyceride values months months triglycerides pretreatment levels treatment clofibrate niacin sustained decrease plasma triglyceride levels months findings dietary management GSD-IA improvements triglyceride levels patients triglyceride values mg/dl mmol/L patient biochemical evidence essential fatty acid deficiency